Houston Eye Associates

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Glaucoma6 trials
• High blood pressure4 trials
• Macular degeneration2 trials
• Diabetic eye disease1 trial

Phase

• Phase 24 trials
• Phase 33 trials

Status

• Completed5 trials
• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Apellis Pharmaceuticals, Inc.1 trial
• Avisi Technologies Inc.1 trial
• Bausch & Lomb Incorporated1 trial
• iSTAR Medical1 trial
• Janssen Research & Development, LLC1 trial
• and 4 more

Running trials

• Recruiting

  A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension

  NCT07661329· Phase 3· YS Life Science Co., Ltd.· Source

  Contact: Bhavna Shah, Dr

• Recruiting

  Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

  NCT07220876· Avisi Technologies Inc.· Source

  Contact: Katherine Lee

• Recruiting

  Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

  NCT07218783· Phase 3· SpyGlass Pharma, Inc.· Source

  Contact: Clinical Research Coordinator

• Active, not recruiting

  Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

  NCT05024695· iSTAR Medical· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Glaucoma3 recruiting
• High blood pressure2 recruiting

Closed trials

• Completed

  Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

  NCT07168902· Phase 2· Bausch & Lomb Incorporated· Source

• Completed

  Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension

  NCT06394973· Phase 2· Laboratoires Thea· Source

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Oxurion· Source